↓ Skip to main content

Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil

Overview of attention for article published in Frontiers in Microbiology, March 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
105 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil
Published in
Frontiers in Microbiology, March 2017
DOI 10.3389/fmicb.2017.00298
Pubmed ID
Authors

Ana L. G. Terças, Sirlei G. Marques, Eduardo B. Moffa, Márcia B. Alves, Conceição M. P. S. de Azevedo, Walter L. Siqueira, Cristina A. Monteiro

Abstract

Oropharyngeal candidiasis is the most common fungal infection in hospitalized patients with acquired immune deficiency syndrome (AIDS). Its progression results in invasive infections, which are a significant cause of morbidity and mortality. This study aimed to quickly and accurately identify Candida spp. from oral mucosa of AIDS patients recruited at Presidente Vargas Hospital, in São Luís city, Brazil and to evaluate the sensitivity profile of these fungi to antifungals by using an automated system. Isolates were collected from oropharyngeal mucosa of 52 hospitalized AIDS patients, under anti-viral and antifungal therapies. Patients were included in research if they were HIV-positive, above 18 years of age and after obtaining their written consent. CHROMagar(®)Candida and the automated ViteK-2(®)system were used to isolate and identify Candida spp., respectively. Antifungal susceptibility testing was performed using the ViteK-2(®)system, complemented with the Etest(®), using the drugs amphotericin B, fluconazole, flucytosine, and voriconazole. Oropharyngeal candidiasis had a high prevalence in these hospitalized AIDS patients (83%), and the most prevalent species was Candida albicans (56%). Antifungal susceptibility test showed that 64.7% of the Candida spp. were susceptible, 11.8% were dose-dependent sensitive, and 23.5% were resistant. All the Candida krusei and Candida famata isolates and two of Candida glabrata were resistant to fluconazole. Most of AIDS patients presented oropharyngeal candidiasis and C. albicans was the most frequently isolated species. The results showed high variability in resistance among isolated species and indicates the need to identify the Candida spp. involved in the infection and the need to test antifungal susceptibility as a guide in drug therapy in patients hospitalized with AIDS. This is the first relate about AIDS patients monitoring in a public hospital in São Luís concerning the precise identification and establishing of antifungal profile of Candida spp..

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 <1%
Unknown 104 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 18%
Student > Bachelor 18 17%
Student > Doctoral Student 9 9%
Student > Ph. D. Student 5 5%
Professor 4 4%
Other 16 15%
Unknown 34 32%
Readers by discipline Count As %
Medicine and Dentistry 16 15%
Immunology and Microbiology 16 15%
Biochemistry, Genetics and Molecular Biology 13 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 8%
Agricultural and Biological Sciences 8 8%
Other 5 5%
Unknown 39 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#16,510,962
of 24,294,766 outputs
Outputs from Frontiers in Microbiology
#16,921
of 27,463 outputs
Outputs of similar age
#202,311
of 314,586 outputs
Outputs of similar age from Frontiers in Microbiology
#326
of 455 outputs
Altmetric has tracked 24,294,766 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 27,463 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,586 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 455 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.